TDO2 and hepatocellular carcinoma: This result suggests a potential role for TDO2 in inhibiting the progression of HCC; however, it was based on RNA sequencing and bioinformatics analysis, with only simple qPCR verification, lacking direct validation through in vivo or additional in vitro experiments [112].